Totals
- Total revenue
- $15,213,970
- Total expenses
- $14,019,399
- Contributions and grants received
- $7,673,243
- Grants paid
- $2,564,862
- Program service revenue
- $6,912,298
- Investment income
- $209,381
- Other revenue
- $419,048
- Total assets, end of year
- $10,645,251
- Total liabilities, end of year
- $3,222,762
- Net assets or fund balances, end of year
- $7,422,489
- Program services expenses (Part IX)
- $10,840,169
- Management and general expenses
- $1,300,650
- Fundraising expenses
- $1,878,580
- Program service expenses (Part III)
- $10,840,169
Program services were 77.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c , Fundraising events
$2,630,216
-
1f , All other contributions, gifts and grants
$5,043,027
-
1g , Noncash contributions included above
$126,484
-
2a , Program service revenue: ANNUAL CONFERENCE
total $4,504,249 · related or exempt $4,504,249
-
2b , Program service revenue: INDUSTRY SPONSORED RESEARCH
total $1,593,049 · related or exempt $1,593,049
-
2c , Program service revenue: SUMMIT OF STRENGTH SYMPOSIUMS
total $815,000 · related or exempt $815,000
-
3 , Investment income
total $152,824 · excluded $152,824
-
7a , Gross sales of assets other than inventory
securities $476,058
-
7b , Less cost or other basis and sales expenses
securities $419,501
-
7c , Gain or loss
securities $56,557
-
7d , Net gain or loss
total $56,557 · excluded $56,557
-
8a , Fundraising events: gross income
$709,219
-
8a , Fundraising events: contributions included on line 1c
$2,630,216
-
8b , Fundraising events: direct expenses
$604,578
-
8c , Net income from fundraising events
total $104,641 · excluded $104,641
-
11a , Other revenue: HOTEL COMMISSIONS
total $159,514 · related or exempt $159,514
-
11b , Other revenue: LEASE CANCELLATION
total $112,500 · related or exempt $112,500
-
11c , Other revenue: STORE MERCHANDISE
total $24,454 · related or exempt $24,454
-
11d , All other revenue
total $17,939 · related or exempt $17,939
-
11e , Other revenue, total
$314,407
Functional expenses
Part IX, the statement of functional expenses.
-
1 , Grants to domestic organizations and governments
total $1,802,574 · program services $1,802,574
-
2 , Grants to domestic individuals
total $196,619 · program services $196,619
-
3 , Grants to foreign organizations and individuals
total $565,669 · program services $565,669
-
5 , Compensation of officers, directors and key employees
total $1,168,801 · program services $541,662 · management and general $188,361 · fundraising $438,778
-
7 , Other salaries and wages
total $3,747,629 · program services $2,323,971 · management and general $552,700 · fundraising $870,958
-
8 , Pension plan contributions
total $98,683 · program services $62,575 · management and general $14,285 · fundraising $21,823
-
9 , Other employee benefits
total $319,066 · program services $194,954 · management and general $45,848 · fundraising $78,264
-
10 , Payroll taxes
total $348,964 · program services $204,319 · management and general $52,414 · fundraising $92,231
-
11b , Fees: legal
total $4,425 · management and general $4,425
-
11c , Fees: accounting
total $36,050 · management and general $36,050
-
11f , Fees: investment management
total $18,750 · management and general $18,750
-
11g , Fees: other
total $550,314 · program services $527,293 · management and general $5,371 · fundraising $17,650
-
12 , Advertising and promotion
total $33,092 · program services $23,820 · management and general $4,806 · fundraising $4,466
-
13 , Office expenses
total $384,534 · program services $324,550 · management and general $18,238 · fundraising $41,746
-
14 , Information technology
total $451,247 · program services $315,874 · management and general $31,586 · fundraising $103,787
-
16 , Occupancy
total $123,018 · program services $72,028 · management and general $18,476 · fundraising $32,514
-
17 , Travel
total $204,728 · program services $119,869 · management and general $30,749 · fundraising $54,110
-
19 , Conferences, conventions and meetings
total $3,412,351 · program services $3,268,889 · management and general $115,465 · fundraising $27,997
-
22 , Depreciation, depletion and amortization
total $135,755 · program services $120,930 · management and general $5,372 · fundraising $9,453
-
23 , Insurance
total $43,929 · program services $19,130 · management and general $16,163 · fundraising $8,636
-
24a , Other expenses: BANK CHARGES, CREDIT CA
total $127,631 · management and general $87,298 · fundraising $40,333
-
24b , Other expenses: WEBSITE
total $114,664 · program services $85,998 · management and general $5,733 · fundraising $22,933
-
24c , Other expenses: PROMOTIONAL ITEMS
total $41,402 · program services $37,245 · management and general $4,157
-
24d , Other expenses: DUES AND SUBSCRIPTIONS/
total $28,910 · program services $11,475 · management and general $10,338 · fundraising $7,097
-
24e , All other expenses
total $60,594 · program services $20,725 · management and general $34,065 · fundraising $5,804
Balance sheet
Part X, book values.
-
1 , Cash, non-interest-bearing
beginning of year $3,808,783 · end of year $4,762,767
-
3 , Pledges and grants receivable
beginning of year $4,000,444 · end of year $3,183,431
-
9 , Prepaid expenses and deferred charges
beginning of year $223,881 · end of year $226,893
-
10a , Land, buildings and equipment: cost or other basis
$855,101
-
10b , Land, buildings and equipment: accumulated depreciation
$796,016
-
10c , Land, buildings and equipment, net
beginning of year $161,593 · end of year $59,085
-
11 , Investments: publicly traded securities
beginning of year $2,291,309 · end of year $2,391,493
-
14 , Intangible assets
beginning of year $33,647 · end of year $1,588
-
15 , Other assets
beginning of year $184,311 · end of year $19,994
-
17 , Accounts payable and accrued expenses
beginning of year $2,962,429 · end of year $1,842,564
-
18 , Grants payable
beginning of year $1,245,367 · end of year $1,201,221
-
25 , Other liabilities
beginning of year $374,843 · end of year $178,977
-
27 , Net assets without donor restrictions
beginning of year $1,424,129 · end of year $2,609,833
-
28 , Net assets with donor restrictions
beginning of year $4,697,200 · end of year $4,812,656
Mission and programs · 2024
Mission
OUR MISSION IS TO DRIVE RESEARCH FOR TREATMENTS AND A CURE FOR SMA, AND TO SUPPORT AND EMPOWER EVERYONE IMPACTED BY SMA TODAY.
Activities or mission (Part I)
TO DRIVE RESEARCH FOR TREATMENTS AND A CURE FOR SMA, AND TO SUPPORT AND EMPOWER EVERYONE IMPACTED BY SMA TODAY.
-
INDIVIDUALS WITH SMA NEED SPECIALIZED CARE AND EQUIPMENT, WHICH CAN PUT ENORMOUS LOGISTICAL AND FINANCIAL PRESSURE ON FAMILIES. CURE SMA IS COMMITTED TO MAKING SURE THAT FAMILIES HAVE THE BEST, MOST ACCURATE INFORMATION ABOUT SMA AND WHAT IT MEANS FOR THEM, AND TO MAKING SURE THAT THEY UNDERSTAND ALL THE OPTIONS AND RESOURCES AVAILABLE TO THEM FROM DAY-TO-DAY CARE TO THE CHANGING LANDSCAPE OF RESEARCH BREAKTHROUGHS AND TREATMENTS. THIS INCLUDES OUR CARE SERIES BOOKLETS, WHICH ARE SENT OUT AS PART OF INFORMATIONAL PACKETS AVAILABLE AT NO COST TO ANYONE WHO REQUESTS ONE. DEVELOPED BY MEDICAL EXPERTS AND REVIEWED BY FAMILIES, THESE BOOKLETS COVER TOPICS SUCH AS BREATHING, NUTRITION, PALLIATIVE CARE, GENETICS, MUSCULOSKELETAL ISSUES, AND MORE. IN ADDITION, OUR EQUIPMENT POOL GIVES FAMILIES ACCESS TO SPECIALIZED ITEMS LIKE CAR BEDS, STROLLERS AND BATHING SYSTEMS AT NO COST. EVERY NEWLY-DIAGNOSED FAMILY RECEIVES A CARE PACKAGE FROM CURE SMA, FULL OF TOYS APPROPRIATE TO THE CHILD'S TYPE OF THE DISEASE, IMPARTIAL INFORMATION FOR PARENTS, AND USEFUL ITEMS SUGGESTED BY OTHER SMA PARENTS BASED ON THEIR OWN EXPERIENCES. EVERY NEW ADULT TO THE COMMUNITY RECEIVES A PACKAGES OF SPECIAL INDEPENDENCE RELATED ITEMS.CURE SMA ALSO EDUCATES THE PUBLIC ABOUT SMA, TO STRENGTHEN THE SUPPORT AVAILABLE TO FAMILIES. THIS INCLUDES DIRECTIONS, A BIANNUAL FAMILY SUPPORT NEWSLETTER, AND COMPASS, A QUARTERLY UPDATE ON RESEARCH DEVELOPMENTS
Expenses $4,835,026 · Grants $196,619 · Revenue $245,468
-
CURE SMA FOCUSES ON THREE DIFFERENT YET EQUALLY CRITICAL AND INTERDEPENDENT RESEARCH AREAS: BASIC RESEARCH, TO UNDERSTAND THE CAUSE AND BIOLOGY OF SMA; DRUG DISCOVERY, TO CONVERT BASIC RESEARCH IDEAS INTO PRACTICAL NEW DRUG CANDIDATES; AND CLINICAL & REGULATORY RESEARCH, TO PROVIDE THE INFRASTRUCTURE TO TEST THE DRUG CANDIDATES. DURING THIS PERIOD CURE SMA FUNDED SIX NEW AND SIX ONGOING BASIC RESEARCH GRANTS. WE ALSO FUNDED AND EXECUTED MULTIPLE CLINICAL AND REGULATORY FOCUSED PROJECTS, TO INCREASE SMA CLINICAL TRIAL SITE CAPACITY AND READINESS, TO PROVIDE REGULATORY AUTHORITIES WITH DATA ON THE SMA POPULATION AND THEIR REPORTED UNMET NEEDS, AND TO COLLECT DATA TO UNDERSTAND THE PATIENT EXPERIENCE WITH SMA. CURRENTLY, THERE ARE THREE APPROVED DRUGS FOR SMA, WITH ANOTHER SEVERAL DOZEN DRUG PROGRAMS IN DEVELOPMENT, INCLUDING FIVE IN CLINICAL TRIALS. CURRENTLY, TWO INVESTIGATIONAL DRUGS ARE AWAITING FDA APPROVAL.CURE SMA HAVE THREE PRIMARY DATABASES FOR DATA COLLECTION: A PATIENT-REPORTED DATABASE WITH DATA FROM OVER 11,000 IMPACTED INDIVIDUALS WORLDWIDE THAT ALSO INCORPORATES LONGITUDINAL DATA FROM OUR ANNUAL COMMUNITY UPDATE SURVEY; THE SMA CLINICAL DATA REGISTRY (CDR) THAT CONTAINS ELECTRONIC MEDICAL RECORD (EMR) SOURCED DATA FROM U.S. BASED SMA CARE CENTER NETWORK SITES; AND THE NEWBORN SCREENING REGISTRY WITH DATA FROM PARENTS OF BABIES WITH SMA THAT WERE IDENTIFIED THROUGH STATEWIDE SMA NEWBORN SCREENING. THE ABOVE DATA SOURCES ARE COMBINED AND ANALYZED ANNUALLY TO IDENTIFY TRENDS IN DEMOGRAPHICS, DIAGNOSIS, SMA TREATMENTS, UNMET NEEDS, PATIENT CARE AND OUTCOMES. THE MOST RECENT ANALYZES WERE PUBLISHED IN THE STATE OF SMA 2024 REPORT AVAILABLE ON OUR WEBSITE. DATA COLLECTED IS ALSO SHARED IN PEER-REVIEWED LITERATURE. CURE SMA PUBLISHED "SMA COMMUNITY PRIORITIES FOR FUTURE DRUG THERAPIES: CROSS-SECTIONAL SURVEY FINDING REPRESENTING 410 ADULTS WITH SMA" IN NEUROLOGY AND THERAPY IN JUNE 2025. IN ADDITION, CURE SMA SUPPORTS THE SMA INDUSTRY COLLABORATION. ESTABLISHED IN 2016, THE COLLABORATION IS A MULTI-FACETED PARTNERSHIP THAT BRINGS TOGETHER PHARMACEUTICAL COMPANIES, CURE SMA, AND OTHER NONPROFIT ORGANIZATIONS TO SHARE INFORMATION, IDEAS, AND DATA. THE SMA INDUSTRY COLLABORATION WORKS TOGETHER TO ADDRESS SCIENTIFIC, CLINICAL, AND REGULATORY TOPICS THAT ARE CRITICAL TO ADVANCING DRUG DEVELOPMENT IN SMA AND WILL BENEFIT THE BROADER SMA COMMUNITY. CURE SMA CO-CREATED A NEW HEALTHCARE PROVIDER ENDURING CONTINUING MEDICAL EDUCATION PROGRAM IN ADDITION TO THE IN-PERSON CURE SMA CLINICAL CARE SESSION OFFERED IN JUNE 2025. RESOURCES WERE ALSO DEVOTED TO MAINTAINING WEBSITE LISTINGS OF SMA NEWBORN SCREENING REFERRAL CENTERS AND TREATMENT CENTERS THAT PROVIDE FDA-APPROVED SMA TREATMENTS.
Expenses $5,416,203 · Grants $2,368,243 · Revenue $1,650,318
-
WE HOSTED THE 2025 ANNUAL SMA CONFERENCE IN ANAHEIM, CA WITH OVER 2,739 REGISTERED ATTENDEES. OUR ANNUAL CONFERENCE IS AN INVALUABLE RESOURCE FOR THE ENTIRE SMA COMMUNITY. THE CONFERENCE IS THE LARGEST IN THE WORLD FOCUSED SPECIFICALLY ON SMA. THE RESEARCHER AND CLINICAL CARE CONFERENCE ATTRACTED THE TOP SCIENTISTS AND COMPANIES IN THE FIELD. THE COMMUNITY CONFERENCE INCLUDES A VARIETY OF WORKSHOPS, KEYNOTE SESSIONS WITH LEADING EXPERTS, AND MORE-PLUS GREAT EVENTS SUCH AS OUR TEEN AND ADULTS WITH SMA SOCIALS, THE FAMILY FRIENDLY RESEARCHER POSTER SESSION AND OUR MEET & GREET, WITH A FAMILY FUN FEST. THE RESEARCHER AND CLINICAL CARE CONFERENCE CREATES OPEN COMMUNICATION OF EARLY, UNPUBLISHED SCIENTIFIC DATA, ACCELERATING THE PACE OF RESEARCH. THE MEETING ALSO FURTHERS RESEARCH BY BUILDING PRODUCTIVE COLLABORATIONSINCLUDING CROSS-DISCIPLINARY DIALOGUE, PARTNERSHIPS, INTEGRATION OF NEW RESEARCHERS AND DRUG COMPANIES, AND EDUCATIONAL OPPORTUNITIES FOR JUNIOR RESEARCHERS. COMMUNITY ATTENDEES HAVE DIRECT ACCESS TO THE LATEST INFORMATION ABOUT RESEARCH, AND RESEARCHERS HAVE AN OPPORTUNITY TO BUILD PERSONAL CONNECTIONS WITH THE PATIENTS WHO WILL BENEFIT FROM THEIR WORK.
Expenses $588,940 · Revenue $5,330,919
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Robert GrahamROBERT GRAHAM
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Peter StatilePETER STATILE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Mark MooreMARK MOORE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Marc GinskyMARC GINSKY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Karen McRoy-NegrinKAREN MCROY-NEGRIN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Bakri ElsheikhBAKRI ELSHEIKH
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Joe WisemanJOE WISEMAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Rob LockwoodROB LOCKWOOD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Kelly JankowskiKELLY JANKOWSKI
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Amy MedinaAMY MEDINA
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Gillian MullinsGILLIAN MULLINS
DIRECTOR (THROUGH 12/31/24)
- Total calculated
- $0
- Hours/week
- 2
-
Edmund LeeEDMUND LEE
DIRECTOR (THROUGH 12/31/24)
- Total calculated
- $0
- Hours/week
- 2
-
Diana CastroDIANA CASTRO
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Brian SnyderBRIAN SNYDER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Brianna GrossBRIANNA GROSS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Jaclyn GreenwoodJACLYN GREENWOOD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Corey BraastadCOREY BRAASTAD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Allyson HenkelALLYSON HENKEL
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Collin PollockCOLLIN POLLOCK
DIRECTOR (START 4/26/25)
- Total calculated
- $0
- Hours/week
- 2
-
Rachel BrownRACHEL BROWN
DIRECTOR (START 4/26/25)
- Total calculated
- $0
- Hours/week
- 2
-
Tyler DukesTYLER DUKES
DIRECTOR (START 4/26/25)
- Total calculated
- $0
- Hours/week
- 2
-
Kaleen RobinsonKALEEN ROBINSON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Spencer PerlmanSPENCER PERLMAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Nick FarrellNICK FARRELL
BOARD CHAIR
- Total calculated
- $0
- Hours/week
- 5
-
Bradley A NunemakerBRADLEY A NUNEMAKER
TREASURER & VICE CHAIR
- Total calculated
- $0
- Hours/week
- 5
-
Shannon ZerzanSHANNON ZERZAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 5
-
John WeberJOHN WEBER
DIRECTOR (START 10/1/2024)
- Total calculated
- $0
- Hours/week
- 2
-
Kenneth HobbyKENNETH HOBBY
PRESIDENT
- Total calculated
- $348,806
- From this org
- $329,195
- From related orgs
- $0
- Other
- $19,611
- Hours/week
- 70
Schedule J breakdown matched by us
- Base
- $329,195
- Bonus
- $0
- Other
- $0
- Deferred
- $12,244
- Nontaxable benefits
- $7,367
- Filer's total
- $348,806
-
Jamie GibsonJAMIE GIBSON
CHIEF DEVELOPMENT OFFICER
- Total calculated
- $294,579
- From this org
- $266,038
- From related orgs
- $0
- Other
- $28,541
- Hours/week
- 60
Schedule J breakdown matched by us
- Base
- $266,038
- Bonus
- $0
- Other
- $0
- Deferred
- $9,619
- Nontaxable benefits
- $18,922
- Filer's total
- $294,579
-
Mary SchrothMARY SCHROTH
CHIEF MEDICAL OFFICER (THROUGH 3/31/25)
- Total calculated
- $228,544
- From this org
- $218,342
- From related orgs
- $0
- Other
- $10,202
- Hours/week
- 60
Schedule J breakdown matched by us
- Base
- $218,342
- Bonus
- $0
- Other
- $0
- Deferred
- $8,841
- Nontaxable benefits
- $1,361
- Filer's total
- $228,544
-
Marline PaganMARLINE PAGAN
CHIEF OPERATING OFFICER
- Total calculated
- $239,457
- From this org
- $208,905
- From related orgs
- $0
- Other
- $30,552
- Hours/week
- 60
Schedule J breakdown matched by us
- Base
- $208,905
- Bonus
- $0
- Other
- $0
- Deferred
- $9,202
- Nontaxable benefits
- $21,350
- Filer's total
- $239,457
-
Jesse AynesJESSE AYNES
VICE PRESIDENT OF DEVELOPMENT
- Total calculated
- $145,118
- From this org
- $135,299
- From related orgs
- $0
- Other
- $9,819
- Hours/week
- 50
-
Mary CurryMARY CURRY
VICE PRESIDENT, CLINICAL RESEARCH & CARE
- Total calculated
- $158,715
- From this org
- $138,474
- From related orgs
- $0
- Other
- $20,241
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $138,474
- Bonus
- $0
- Other
- $0
- Deferred
- $6,111
- Nontaxable benefits
- $14,130
- Filer's total
- $158,715
-
Maynard FrieszMAYNARD FRIESZ
VICE PRESIDENT, POLICY
- Total calculated
- $163,143
- From this org
- $149,595
- From related orgs
- $0
- Other
- $13,548
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $149,595
- Bonus
- $0
- Other
- $0
- Deferred
- $5,879
- Nontaxable benefits
- $7,669
- Filer's total
- $163,143
-
Jackie GlascockJACKIE GLASCOCK
VICE PRESIDENT OF RESEARCH
- Total calculated
- $153,657
- From this org
- $146,346
- From related orgs
- $0
- Other
- $7,311
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $146,346
- Bonus
- $0
- Other
- $0
- Deferred
- $6,067
- Nontaxable benefits
- $1,244
- Filer's total
- $153,657
-
Colleen McCarthy O'TooleCOLLEEN MCCARTHY O'TOOLE
SR VICE PRESIDENT, COMMUNI
- Total calculated
- $202,496
- From this org
- $175,435
- From related orgs
- $0
- Other
- $27,061
- Hours/week
- 60
Schedule J breakdown matched by us
- Base
- $175,435
- Bonus
- $0
- Other
- $0
- Deferred
- $5,746
- Nontaxable benefits
- $21,315
- Filer's total
- $202,496
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINE 3
- APPROVED BY THE BOARD OF DIRECTORS. THE BOARD'S EXECUTIVE COMMITTEE CONDUCTS A MARKET SURVEY OF THE POSITION USING INDEPENDENT COMPENSATION SOURCES, AND THEN PRESENTS A RECOMMENDATION TO THE FULL BOARD FOR APPROVAL.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$346,620
PNCR NETWORK & BASIC RESEARCH
-
PNCR NETWORK & BASIC RESEARCH
-
PNCR NETWORK & BASIC RESEARCH
-
LELAND STANFORD JUNIOR UNIVERSITY
$252,500
PNCR NETWORK
-
$230,000
PNCR NETWORK
-
CHILDREN'S HOSPITAL OF PHILADELPHIA
$164,300
PNCR NETWORK
-
$149,695
BASIC RESEARCH
-
$44,169
BASIC RESEARCH
-
BASIC RESEARCH
Fundraising and gaming
From Schedule G of this return, as filed.
- Had an agreement with a professional fundraiser (line 2a)
- Not answered
Fundraising events (Part II)
Part II has at most four columns: the two largest events, the rest together, and the total.
| Line | Event 1 CURE FOR CASEY | Event 2 HOPE ON THE HILL | Other events 48 events | Total |
|---|---|---|---|---|
| Gross receipts (line 1) | $265,339 | $151,795 | $2,922,301 | $3,339,435 |
| Less contributions (line 2) | $256,088 | $116,568 | $2,257,560 | $2,630,216 |
| Gross income (line 3) | $9,251 | $35,227 | $664,741 | $709,219 |
| Cash prizes (line 4) | — | — | — | — |
| Noncash prizes (line 5) | $3,259 | — | $77,180 | $80,439 |
| Rent and facility costs (line 6) | — | $10,461 | $38,242 | $48,703 |
| Food and beverages (line 7) | $9,251 | $35,227 | $109,076 | $153,554 |
| Entertainment (line 8) | $3,250 | $682 | $27,165 | $31,097 |
| Other direct expenses (line 9) | $40,449 | $12,906 | $237,430 | $290,785 |
- Direct expenses (line 10)
- $604,578
- Net income (line 11)
- $104,641
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 0
- Expenditures and investments (line 3c)
- $565,669
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | GRANTS TO RECIPIENTS IN THE REGION. | GRANTS.LIST 59 _ 2AKOTLOVA - 10/23/24 09:18PM WORKSHEET FORM 990 - SCH F (PART I) _ 1372 | $515,669 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANTS TO RECIPIENTS IN THE REGION. | GRANTS | $50,000 |
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | $147,836 | WIRE TRANSFER | $0 | — | CASH VALUE |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | $364,960 | WIRE TRANSFER | $0 | — | CASH VALUE |
| EAST ASIA AND THE PACIFIC | $50,000 | WIRE TRANSFER | $0 | — | CASH VALUE |
- Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
- 0
- Other grantees (Part II line 3)
- 6
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 12 November 2025
- IRS schema version
- 2024v5.2
- Source object
- 202513169349304516
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.